Pharmaceutical drug

Nusinersen (Under CC License)

Nusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder. Nusinersen has orphan drug designation in the United States and the European Union.

Nusinersen News and Videos   LIVE

ℹī¸ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets
A drug that can slow the effects of spinal muscular atrophy is approved for use on the NHS.
6 days ago • BBC News


You might like